BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4066562)

  • 1. Comparison of long-term, low-dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children. An open, randomized, cross-over study.
    Carlsen NL; Hesselbjerg U; Glenting P
    J Antimicrob Chemother; 1985 Oct; 16(4):509-17. PubMed ID: 4066562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of long-term treatment with mecillinam on fecal Escherichia coli.
    Møller JK; Stenderup A
    Scand J Infect Dis; 1984; 16(2):223-4. PubMed ID: 6330882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of 3-day and 7-day chemotherapy with twice-daily pivmecillinam in urinary tract infections seen in general practice.
    Richards HH
    Curr Med Res Opin; 1984; 9(3):197-203. PubMed ID: 6499513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro sensitivity of organisms causing urinary tract infections to four common oral antibiotics and to pivmecillinam.
    Bansal AS
    West Indian Med J; 1988 Dec; 37(4):201-4. PubMed ID: 3266047
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men.
    Montelin H; Forsman KJ; Tängdén T
    PLoS One; 2019; 14(1):e0211098. PubMed ID: 30682092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin vs. pivmecillinam in the treatment of uncomplicated lower urinary tract infections in hospitalized elderly patients.
    Jonsson M; Englund G; Nörgård K
    Scand J Infect Dis; 1990; 22(3):339-44. PubMed ID: 2196670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general practice evaluation of pivmecillinam given twice daily as a treatment for acute urinary tract infection.
    Skinner JL; Venables TL; Sheldon MG
    Pharmatherapeutica; 1984; 4(1):25-31. PubMed ID: 6504945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of pivmecillinam hydrochloride in lower urinary tract infections in pregnant women. Apropos of 44 cases].
    Henrion R; Vige P
    Rev Fr Gynecol Obstet; 1987 Dec; 82(12):761-4. PubMed ID: 3324273
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term treatment of acute urinary tract infection in girls. Copenhagen Study Group of Urinary Tract Infections in Children.
    Scand J Infect Dis; 1991; 23(2):213-20. PubMed ID: 1853170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short treatment regimen of lower urinary tract infections by pivmecillinam.
    Van Poppel H; Boeckx G; Broeckman J; Doupagne M; Opsomer RJ
    Acta Urol Belg; 1987; 55(3):479-84. PubMed ID: 3661328
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Titelman E; Iversen A; Kalin M; Giske CG
    Microb Drug Resist; 2012 Apr; 18(2):189-92. PubMed ID: 22204597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
    Menday AP
    Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three- and ten-day regimens with a sulfadiazine-trimethoprim combination and pivmecillinam in acute lower urinary tract infections.
    Gordin A; Kalima S; Mäkelä P; Antikainen R
    Scand J Infect Dis; 1987; 19(1):97-102. PubMed ID: 3563430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
    BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections.
    Hovelius B; Mårdh PA; Nygaard-Pedersen L; Wathne B
    Scand J Prim Health Care; 1985 Nov; 3(4):227-32. PubMed ID: 4081404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with pivmecillinam in patients with recurrent bacteriuria.
    Bresky B; Lincoln K
    J Int Med Res; 1982; 10(3):179-82. PubMed ID: 6284565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic recurrent urinary tract infections. Preventive long-term treatment with pivmecillinam].
    Saltvedt E; Schøyen R; Binde B
    Tidsskr Nor Laegeforen; 1987 May; 107(14):1215-6. PubMed ID: 3603482
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of pivmecillinam in intractable urinary-tract infections with complications. A comparative study with amoxicillin by a randomized double-blind technique.
    Ishigami J; Tanikaze S; Miyazaki S; Ono S; Kuroda M; Hirooka K; Mita T; Sugimoto M; Kuroda K; Nakatsuka E; Suemitsu H; Tomioka S; Takahashi Y; Hara S; Terasoma K; Tanaka K; Ueharaguchi H; Hikosaka K; Yasumuro T; Kaneda K; Akita Y; Okano H; Kobayashi M; Kataoka N
    Jpn J Antibiot; 1977 Nov; 30(11):928-39. PubMed ID: 201786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination.
    Andersen BT; Joergensen M; Lorenzen J
    Infection; 1980; 8(1):27-31. PubMed ID: 6246005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection.
    Norinder BS; Norrby R; Palmgren AC; Hollenberg S; Eriksson U; Nord CE
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1528-30. PubMed ID: 16569875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.